Cargando…
A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188817/ https://www.ncbi.nlm.nih.gov/pubmed/35667483 http://dx.doi.org/10.1016/j.jinf.2022.06.001 |